Get the Stockscreener App
1.25
3.31%
0.04
Pre-market:
1.25
Ispecimen Inc stock is traded at $1.25, with a volume of 3.94M.
It is up +3.31% in the last 24 hours and down -20.38% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$1.21
Open:
$1.24
24h Volume:
3.94M
Relative Volume:
7.65
Market Cap:
$3.15M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.0189
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
-7.41%
1M Performance:
-20.38%
6M Performance:
-79.51%
1Y Performance:
-97.81%
1-Day Range:
$1.2204
$1.28
1-Week Range:
$1.21
$1.39
52-Week Range:
$1.21
$58.40
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
1.25 | 3.15M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
678.39 | 250.83B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
223.77 | 157.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.79 | 58.92B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.84 | 48.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
275.02 | 45.27B | 16.63B | 1.39B | 2.12B | 8.0674 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen stock gains on Nasdaq after a firm session - AD HOC NEWS
iSpecimen stock holds at USD 1.33 as trading stays light - AD HOC NEWS
Ispecimen Stock Price Forecast. Should You Buy ISPC? - StockInvest.us
Up to 80% discounts on future financings at iSpecimen (NASDAQ: ISPC) hinge on a shareholder vote. - Stock Titan
iSpecimen Granted Nasdaq Extension to Regain Compliance - TipRanks
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
ISPC Stock Holds Ground As iSpecimen Delivers Cancer Research Milestone - timothysykes.com
ISPC Stock Draws Attention After Major Cancer Research Win - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ISPC Stock Draws Traders As Cancer Order Highlights Global Reach - timothysykes.com
ISPC Stock Draws Traders After Rapid Cancer Project Win - StocksToTrade
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Benzinga
ISPECIMENDEAL VALUED AT $4.50 MLN: $2 MLN CASH, $2.50 MLN IN COMMON STOCKSEC FILING - Moomoo
iSpecimen to Acquire AI Assets from Foldlab AI for $4.5 Million - minichart.com.sg
iSpecimen to Acquire Foldlab AI Disease Analytics - TipRanks
iSpecimen (NASDAQ: ISPC) lines up reverse split and financings at up to an 80% discount - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4 - TradingView
iSpecimen to Acquire Foldlab AI Assets for $4.5 Million, Stock in 5-Year Escrow - TradingView
ISpecimenEnters Asset Purchase Agreement W - Moomoo
Five-year lock-up anchors iSpecimen (NASDAQ: ISPC) AI asset deal - Stock Titan
ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million. - marketscreener.com
ISPC Q3 2024 Earnings: Severe EPS Miss Highlights Ongoing ChallengesEarnings Turnaround - dars.gov.et
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - vinanet.vn
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Nigeria
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
ISPC Stock Quote Price and Forecast - CNN
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Flags Going Concern Doubt After Q2 Revenue Falls 79% - Minichart
iSpecimen Pays $2 Million for Three-Month Marketing Agreement - minichart.com.sg
iSpecimen Engages IR Agency for Investor Marketing - TipRanks
iSpecimen (ISPC) revenue drops to $308K as losses deepen and cash burns - Stock Titan
iSpecimen | 10-Q: Q2 2026 Earnings Report - Moomoo
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
iSpecimen Settles Arbitration and Terminates WestPark Agreements - The Globe and Mail
iSpecimen settles arbitration with WestPark Capital for $97,500, ends agreements - Investing.com South Africa
Form 8K iSpecimen Inc For: 11 August By Investing.com - Investing.com Nigeria
IspecimenEnters Settlement Agreement With Westpark Capital On August 6, 2026 - TradingView
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
E.F. Hutton serves as placement agent for iSpecimen $5M offering By Investing.com - Investing.com India
E.F. Hutton serves as agent for iSpecimen $5M offering By Investing.com - Investing.com UK
iSpecimen Inc. Prices $5 Million Public Offering of Common Stock and Pre-Funded Warrants to Fuel Growth and Innovation – Minichart - Minichart
iSpecimen Inc (ISPC) Stock News Today - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):